Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 and ED95 of unilateral spinal anesthesia with hyperbaric ropivacaine
ChiCTR2400088340Phase 4Recruiting
- Sponsor
- Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College
- Start
- Aug 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine in Varicose veins of lower extremities (VVLE) (2 arms), sponsored by Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College. Primary endpoint: ED50 and ED95 of unilateral spinal anesthesia with hyperbaric ropivacaine to achieve motor block only in the affected side. Started Aug 2024; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
Varicose veins of lower extremities (VVLE)
Beyond the preview
Go deeper on ChiCTR2400088340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088340.